Physician profile
John G Olinde
NPI 1306822762
$1,951.56
in general payments reported to CMS, 2019-2025
31 companies · $94.96 in 2025
The $94.96 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $787 · 2020: $271 · 2021: $300 · 2022: $61.96 · 2023: $110 · 2024: $326 · 2025: $94.96.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $532.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $531.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $847.35 | 2019-2023 | Da Vinci Surgical System |
| Axonics, INC. | $144.37 | 2024 | Axonics |
| Merck Sharp & Dohme LLC | $114.97 | 2021-2025 | Keytruda |
| Biocomposites INC | $102.10 | 2021 | |
| Servier Pharmaceuticals LLC | $87.98 | 2024 | |
| Allergan, INC. | $80.35 | 2019-2022 | |
| Pfizer INC. | $78.97 | 2024 | |
| Novartis Pharmaceuticals Corporation | $48.64 | 2019-2021 | |
| Hologic Sales and Service, LLC | $32.58 | 2023 | Coolseal Generator, Localizer, Trunode |
| Pacira Pharmaceuticals Incorporated | $32.38 | 2019 | |
| Innocoll Pharmaceuticals Limited | $31.01 | 2021 | |
| Baxter Healthcare | $24.51 | 2019 | |
| Abbott Laboratories | $22.84 | 2019 | |
| Endo Pharmaceuticals INC. | $21.08 | 2019 | |
| Tela Bio, INC. | $20.27 | 2020 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baudax Bio INC. | $20.24 | 2022 | |
| Shire North American Group INC | $20.04 | 2019 | |
| Axogen | $19.85 | 2019 | |
| Heron Therapeutics, INC. | $18.74 | 2021 | |
| W. L. Gore & Associates, INC. | $18.34 | 2019 | |
| Amgen INC. | $18.19 | 2019 | |
| Davol INC. | $17.54 | 2019 | |
| Acell, INC. | $16.69 | 2019 | |
| Zimmer Biomet Holdings, INC. | $16.23 | 2020 | |
| Leica Microsystems INC. | $16.15 | 2019 | |
| Innovation Technologies INC | $15.37 | 2020 | |
| Ethicon US, LLC | $15.10 | 2024 | Dermabond Prineo |
| Avanos Medical | $13.08 | 2019 | |
| Bioventus LLC | $12.46 | 2019 | |
| Ermi LLC | $12.28 | 2019 | |
| Checkpoint Surgical, INC | $11.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Olinde listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.